BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13790639)

  • 1. Complement and complement components in diseases of possible auto-immunological pathogenesis.
    JONSEN J; KASS E
    Acta Rheumatol Scand; 1961; 7():21-6. PubMed ID: 13790639
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary activity of the blood in rheumatism and certain allied disorders.
    KELLETT CE
    Ann Rheum Dis; 1954 Sep; 13(3):211-8. PubMed ID: 13198055
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels of C1q, C1r and C1s in normal and pathologic sera.
    De Bracco MM; Manni JA
    Arthritis Rheum; 1974; 17(2):121-8. PubMed ID: 4205506
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physical criteria of pathological processes. III. Structure of the correlation between the level of steady brain potential with serum complement proteins in rheumatic diseases].
    Klimenko LL; Kozlov LV; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Konradov AA; Turna AA; Soiustova EL; Matveev GN
    Biofizika; 1999; 44(1):128-31. PubMed ID: 10330589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological overlap between lupus erythematosus, rheumatoid arthritis, and thyroid auto-immune disease.
    HIJMANS W; DONIACH D; ROITT IM; HOLBOROW EJ
    Br Med J; 1961 Oct; 2(5257):909-14. PubMed ID: 13714204
    [No Abstract]   [Full Text] [Related]  

  • 6. THE PRACTICAL ASPECTS OF AUTO-IMMUNIZATION.
    SERAFINI U
    Acta Allergol; 1963; 18():455-61. PubMed ID: 14120372
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complement system in human pathology].
    Tedesco F
    Recenti Prog Med; 1971 Dec; 51(6):501-26. PubMed ID: 5172401
    [No Abstract]   [Full Text] [Related]  

  • 8. DEOXYRIBONUCLEIC ACID SYNTHESIZING CELLS IN THE PERIPHERAL BLOOD OF PATIENTS WITH "AUTO-IMMUNE" DISORDERS.
    COOPER IA; FIRKIN BG
    Australas Ann Med; 1965 May; 14():142-5. PubMed ID: 14313531
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies of hemolytic complement and the 11S component.
    Hanauer LB; Christian CL
    Am J Med; 1967 Jun; 42(6):882-90. PubMed ID: 6067456
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal serum proteins as aids in diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    BARTON EM
    Med Clin North Am; 1959 Mar; 43(2):607-13. PubMed ID: 13643141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum complement activity. Clinical and humoral correlations].
    Purice S; Ghelerter L; Drăgoi T; Lungu N
    Med Interna (Bucur); 1969 Feb; 21(2):173-80. PubMed ID: 5780235
    [No Abstract]   [Full Text] [Related]  

  • 12. [HEREDITARY FACTORS IN DISSEMINATED LUPUS ERYTHEMATOSUS. CLINICAL AND SEROLOGICAL FAMILIAL INVESTIGATIONS].
    THIVOLET J; VERJUS F; KRATCHKO A
    Ann Dermatol Syphiligr (Paris); 1964; 91():361-78. PubMed ID: 14194827
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.
    Ekdahl KN; Norberg D; Bengtsson AA; Sturfelt G; Nilsson UR; Nilsson B
    Clin Vaccine Immunol; 2007 May; 14(5):549-55. PubMed ID: 17344343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement in immunopathology].
    Eyquem A; de Saint Martin J
    Transfusion (Paris); 1967; 10(3):313-28. PubMed ID: 6076974
    [No Abstract]   [Full Text] [Related]  

  • 15. [PREVALENT 7S TYPE OF ANTISTREPTOLYSINE IN VARIOUS DISEASES].
    PINTO L; PESCE M; DAMMACCO F; BONOMO L
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1368-9. PubMed ID: 14123615
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of serum sialic acid in rheumatoid arthritis and systemic lupus erythematosus].
    Ota T; Uemura A; Eto S; Suzuki H
    J UOEH; 1985 Dec; 7(4):401-7. PubMed ID: 3878988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever.
    Hacbarth E; Kajdacsy-Balla A
    Arthritis Rheum; 1986 Nov; 29(11):1334-42. PubMed ID: 2430586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEPRESSION OF HEMOLYTIC COMPLEMENT ACTIVITY OF SYNOVIAL FLUID IN ADULT RHEUMATOID ARTHRITIS. A PRELIMINARY REPORT.
    HEDBERG H; NORDEN A; LUNDQUIST A; AFZELIUS B
    Acta Med Scand; 1964 Mar; 175():347-51. PubMed ID: 14136249
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON THE DEPRESSED HEMOLYTIC COMPLEMENT ACTIVITY OF SYNOVIAL FLUID IN ADULT RHEUMATOID ARTHRITIS.
    HEDBERG H
    Acta Rheumatol Scand; 1963; 9():165-93. PubMed ID: 14088651
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum levels of RHP and of unbound C1q in rheumatoid arthritis and systemic lupus erythematosus.
    Rosano CL; Parhami N; Hechemy KE; Hurwitz C
    Inflammation; 1988 Aug; 12(4):351-60. PubMed ID: 3262584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.